ArticleCytopathology : official journal of the British Society for Clinical Cytology2026
When Small Cells Matter: Diagnosing Bladder Small Cell Carcinoma on Urine Cytology.
Article in Cytopathology : official journal of the British Society for Clinical Cytology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small cell carcinoma of the urinary bladder (SCCB) is a rare and highly aggressive neuroendocrine neoplasm that poses significant diagnostic challenges, particularly on urine cytology. We report a case of a 68-year-old man with painless hematuria in whom SCCB was initially detected on voided urine cytology. Cytologic evaluation revealed small malignant cells with high nuclear-to-cytoplasmic ratios, nuclear moulding, finely granular chromatin, necrotic background and apoptotic debris, raising suspicion for a neuroendocrine carcinoma. Immunohistochemical studies performed on the urine cell block supported this diagnosis. Subsequent transurethral resection demonstrated a predominant high-grade neuroendocrine carcinoma admixed with conventional high-grade urothelial carcinoma, confirming primary bladder origin. This case highlights the importance of careful cytomorphologic assessment, the diagnostic value of cell block immunohistochemistry and the limitations of the Paris System in classifying non-urothelial malignancies encountered in urine specimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.